R1 RCM
R1 RCM is a United States healthcare revenue-cycle-management company serving hospitals, health systems, and physician groups.
Last updated October 14, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
R1 RCM is a healthcare services company focused on revenue cycle management, the set of administrative and financial processes that support payment collection for medical services. Its work begins when a patient seeks care and extends through registration, insurance eligibility, coding, billing, claims administration, patient billing, collections, and reconciliation of payments from insurers and patients. The company serves hospitals, integrated health systems, and physician organizations rather than selling a conventional consumer product. The business was founded in 2003 as Accretive Health by Mary Tolan and Michael Cline. Tolan led the company as president and chief executive officer for much of its early period, while Cline later served as board chair. Accretive Health expanded by providing hospitals with outsourced or technology-enabled financial and administrative services intended to improve collections, reduce billing inefficiencies, and manage the complexity of reimbursement. Its history has also included significant regulatory, legal, cybersecurity, and reporting challenges. The company attracted regulatory scrutiny in the early 2010s. In 2012, it disclosed laptop thefts involving devices that contained patient data and acknowledged that some company laptops were not encrypted. The resulting matter led to a 20-year Federal Trade Commission settlement in 2013 concerning data-security practices. Accretive Health also reached a 2012 settlement with the Minnesota attorney general concerning debt-collection practices. The company admitted no wrongdoing under that agreement and was restricted from operating in Minnesota for a specified period. Leadership changed substantially during the company's restructuring period. Mary Tolan left the chief executive role in 2013 and was succeeded by Stephen Schuckenbrock, a former Dell executive. Emad Rizk became chief executive officer in July 2014. Accretive Health faced delays in financial reporting and restatements, and its shares were delisted from the New York Stock Exchange in March 2014, although over-the-counter trading continued. The company subsequently completed delayed regulatory filings and continued its operational recovery. A major commercial turning point came in 2015, when Ascension selected Accretive Health as its exclusive hospital revenue-cycle partner. Ascension and TowerBrook Capital Partners invested $200 million to support growth initiatives. In 2017, the company adopted the R1 RCM name and expanded its Ascension relationship to cover additional net patient revenue and physician-group revenue-cycle services. The rebranding reflected the company's repositioning as a broader platform for healthcare financial operations. R1 expanded through acquisitions and service-line additions, including the purchase of the RevWorks business from Cerner Corporation in 2020. That same year, the company experienced a ransomware attack, adding cybersecurity resilience to the operational risks associated with handling sensitive patient and financial information. In 2023, Jehoshaphat Research published a critical report questioning R1's revenue recognition, profit reporting, and assumptions about future collections. The report also highlighted senior executive departures. These allegations were reported as claims by an activist research firm and should not be treated as established findings without independent confirmation. In 2023, R1 settled stockholder litigation alleging breaches of fiduciary duties for $45.4 million in cash. In March 2024, the company reported a data-security incident to the Massachusetts attorney general involving unauthorized access to consumer information, potentially including names, contact details, dates of birth, Social Security numbers, service locations, clinical and diagnosis information, patient account numbers, and medical record numbers. In November 2024, TowerBrook Capital Partners and Clayton, Dubilier & Rice completed the acquisition of R1 RCM in a transaction reported as valuing the company at approximately $8.9 billion. R1 therefore moved from being a publicly traded healthcare-services company to a privately owned platform. Reference material describes the company as employing more than 27,200 people, serving over 1,000 United States clients, and generating approximately $2.1 billion in annual revenue; these figures require date-specific corporate or regulatory sourcing.
History
R1 RCM began in 2003 as Accretive Health, founded by Mary Tolan and Michael Cline to provide financial and administrative services to healthcare providers. Its core field, revenue cycle management, encompasses the processes through which a provider registers patients, verifies coverage, documents and codes care, submits claims, bills patients, collects payments, and reconciles accounts. By outsourcing or improving these functions, hospitals and physician groups can seek to reduce administrative friction and improve the predictability of reimbursement. Tolan served as president and chief executive officer until 2013, while Cline was board chair from 2009 to 2013. The company encountered regulatory and operational difficulties during its early public-company period. In 2012, it responded to a Senate inquiry regarding stolen laptops that held patient data and unencrypted company laptops. The matter resulted in a 20-year FTC settlement in 2013 concerning information-security controls. Accretive Health also settled a Minnesota attorney general investigation into debt-collection practices in 2012 for $2.5 million. The agreement did not include an admission of wrongdoing and imposed a temporary prohibition on operating in Minnesota. Tolan stepped down as chief executive in April 2013 and Stephen Schuckenbrock succeeded her. Emad Rizk replaced Schuckenbrock in July 2014. During this period, delayed financial restatements led to the company's removal from the New York Stock Exchange in March 2014, although over-the-counter trading remained available. Accretive Health later restated certain financial statements, completed its 2014 SEC filings in 2015, and filed its second-quarter 2015 report with the SEC in August of that year. The company received a major commercial boost in 2015 when Ascension chose it as an exclusive hospital revenue-cycle partner. Ascension and TowerBrook Capital Partners invested $200 million in support of growth initiatives. In 2017, Accretive Health changed its name to R1 RCM. The company also expanded its Ascension relationship to cover an additional $1.5 billion in net patient revenue, including revenue-cycle services for physician groups. R1 continued developing its platform through acquisitions and service expansion. In 2020 it acquired Cerner's RevWorks business. The company was subsequently affected by a ransomware attack, underscoring the cyber risk created by its role as a processor of highly sensitive healthcare and financial information. The company's later history included additional investor and data-governance concerns. In October 2023, Jehoshaphat Research issued a report alleging that R1's reported revenues and profits were materially overstated and that some growth depended on assumptions about future collections. The report also referred to departures of several senior executives. In December 2023, R1 settled stockholder litigation alleging fiduciary-duty breaches for $45.4 million in cash. In March 2024, it reported a data breach to Massachusetts authorities involving potentially sensitive personal and medical information. In November 2024, TowerBrook Capital Partners and Clayton, Dubilier & Rice completed the purchase of R1 RCM in a transaction reported at a value of $8.9 billion. The acquisition changed the company's ownership structure from public-market ownership to private equity ownership. Reference material describes R1 as having more than 27,200 employees, over 1,000 United States clients, and approximately $2.1 billion in annual revenue, but the supplied material does not provide sufficiently specific dates and primary-source links for treating those figures as independently verified current metrics.
- 2024
Private-equity acquisition completed
[1]TowerBrook Capital Partners and Clayton, Dubilier & Rice complete the acquisition of R1 RCM at a reported value of approximately $8.9 billion.
- 2020
RevWorks acquisition and ransomware incident
[1]R1 acquires Cerner's RevWorks business and is subsequently affected by a ransomware attack.
- 2017
Rebrand to R1 RCM
[1]Accretive Health adopts the R1 RCM name and expands its Ascension relationship to additional patient revenue and physician-group services.
- 2015
Ascension partnership and growth investment
[1]Ascension selects Accretive Health as its exclusive hospital revenue-cycle partner, with a reported $200 million investment from Ascension and TowerBrook.
- 2014
NYSE delisting and new chief executive
[1]Accretive Health is delisted from the NYSE amid delayed financial restatements, and Emad Rizk becomes chief executive.
- 2013
FTC settlement and chief executive transition
[1]The company enters a long-term FTC data-security settlement, while Mary Tolan leaves the chief executive role and Stephen Schuckenbrock succeeds her.
- 2012
Minnesota settlement and data-security inquiry
[1]Accretive Health settles a Minnesota debt-collection investigation and responds to a Senate inquiry concerning stolen and unencrypted laptops containing patient data.
- 2003
Accretive Health is founded
[1]Mary Tolan and Michael Cline establish the healthcare revenue-cycle-management company that later becomes R1 RCM.
Products and positioning
R1 RCM positions itself as an outsourced and technology-enabled operating partner for healthcare providers, helping organizations manage the administrative path from patient access through reimbursement and collection. Its value proposition centers on specialized healthcare-finance expertise, scale, workflow optimization, and the use of data and technology to improve revenue performance while handling complex payer and patient processes.
Healthcare services
Hospital and health-system revenue cycle management
R1 provides outsourced and technology-enabled support across the hospital revenue cycle. The work can span patient access, registration, insurance eligibility, clinical documentation and coding workflows, claims submission, payer follow-up, patient statements, collections, payment posting, and account reconciliation. The objective is to help hospitals and integrated health systems manage complex reimbursement processes and reduce administrative leakage.
Healthcare services · 2017
Physician-group revenue cycle management
R1's physician-group services extend revenue-cycle operations beyond hospital facilities to affiliated or independent medical practices. These services support the administrative handling of professional claims, payer interactions, patient billing, and collections. The offering became more prominent through the expansion of the company's relationship with Ascension in 2017.
Healthcare revenue-cycle business
RevWorks
RevWorks was a Cerner business line acquired by R1 RCM in 2020. The transaction added revenue-cycle capabilities and customer relationships to R1's healthcare-services platform. The supplied reference material does not provide a detailed product catalogue or separate current branding for the acquired line.
Controversies
2024
Consumer data breach
R1 notified Massachusetts authorities that an unauthorized party had accessed confidential consumer information, potentially including identity, contact, Social Security, clinical, diagnosis, service-location, and patient-account data.
2023
Jehoshaphat Research accounting allegations
Jehoshaphat Research alleged that R1's revenue and profit figures were materially overstated and that reported growth relied on assumptions about future collections. The supplied material identifies these as allegations by the research firm, not adjudicated findings.
2023
Stockholder fiduciary-duty litigation settlement
R1 settled stockholder litigation alleging breaches of fiduciary duties for $45.4 million in cash. The supplied material does not state that the settlement included an admission of liability.
2020
Ransomware attack
R1 RCM was hit by a ransomware attack after its acquisition of Cerner's RevWorks business, creating disruption and cybersecurity concerns for a company handling sensitive healthcare information.
2012
Patient-data laptop security controversy
Accretive Health disclosed that nine laptops containing patient data had been stolen in 2011 and that 30 company laptops lacked encryption. The issue contributed to subsequent federal scrutiny and a long-term FTC settlement.
2012
Minnesota debt-collection investigation
The Minnesota attorney general investigated the company's debt-collection practices. Accretive Health agreed to a $2.5 million settlement, admitted no wrongdoing, and accepted restrictions on operations in the state.
Brand decisions
2024
Acquisition by TowerBrook and Clayton, Dubilier & RiceM&ABackground
The transaction followed R1's period as a publicly traded healthcare-services company.
Action taken
TowerBrook Capital Partners and Clayton, Dubilier & Rice completed the purchase of R1 RCM.
Aftermath
R1 became privately owned; the transaction was reported to value the company at approximately $8.9 billion.
Reported transaction valuation. $8.9 billion (November 2024)
2020
Acquisition of Cerner's RevWorks businessM&ABackground
R1 sought to expand its healthcare revenue-cycle capabilities and customer base.
Action taken
R1 acquired the RevWorks line of business from Cerner Corporation.
Aftermath
The transaction enlarged R1's platform, although the supplied sources do not detail integration results.
2017
Rebrand from Accretive Health to R1 RCMStrategyBackground
The company was broadening its healthcare revenue-cycle platform and expanding beyond its earlier Accretive Health identity.
Action taken
Accretive Health changed its corporate brand name to R1 RCM and expanded its Ascension agreement to include additional hospital and physician-group revenue-cycle activity.
Aftermath
The new name became the company's principal market identity and was associated with broader revenue-cycle-management services.
Recent events
Reported
American Physician Partners extends R1 revenue cycle partnership through 2031[2]
American Physician Partners extended its revenue cycle management partnership with R1 through 2031.
Reported
R1 RCM to acquire Cerner’s RevWorks business[3]
R1 RCM struck a deal to acquire Cerner’s RevWorks business, including its non-federal clients. The deal was expected to close in the third quarter of 2020.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/r1-rcm · Editorial policy · How profiles are compiled